nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessment of Fracture Risk
|
Baim, Sanford |
|
2012 |
10 |
1 |
p. 28-41 |
artikel |
2 |
Can PET-CT Imaging and Radiokinetic Analyses Provide Useful Clinical Information on Atypical Femoral Shaft Fracture in Osteoporotic Patients?
|
Chesnut, C. Haile |
|
2012 |
10 |
1 |
p. 42-47 |
artikel |
3 |
Clinical Use of Bone Turnover Markers to Monitor Pharmacologic Fracture Prevention Therapy
|
Schousboe, John T. |
|
2012 |
10 |
1 |
p. 56-63 |
artikel |
4 |
Data from Extension Trials: Denosumab and Zoledronic Acid
|
Dore, Robin K. |
|
2011 |
10 |
1 |
p. 16-21 |
artikel |
5 |
Inhibition of Cathepsin K for Treatment of Osteoporosis
|
Boonen, Steven |
|
2011 |
10 |
1 |
p. 73-79 |
artikel |
6 |
Letter to the Editor: Regarding “The Utility and Limitations of FRAX: A US Perspective”
|
Czerwinski, Edward |
|
2012 |
10 |
1 |
p. 1-2 |
artikel |
7 |
Nitric Oxide Donors for the Treatment of Osteoporosis
|
Jamal, Sophie A. |
|
2011 |
10 |
1 |
p. 86-92 |
artikel |
8 |
Oral Calcitonin
|
Maricic, Michael J. |
|
2012 |
10 |
1 |
p. 80-85 |
artikel |
9 |
Osteoporosis After Transplantation
|
Kulak, Carolina A. Moreira |
|
2011 |
10 |
1 |
p. 48-55 |
artikel |
10 |
Potential Role for Therapies Targeting DKK1, LRP5, and Serotonin in the Treatment of Osteoporosis
|
Zhang, Wei |
|
2011 |
10 |
1 |
p. 93-100 |
artikel |
11 |
Reply to the Letter by E. Czerwinski Regarding “The Utility and Limitations of FRAX: A US Perspective”
|
Silverman, Stuart L. |
|
2012 |
10 |
1 |
p. 3 |
artikel |
12 |
Sclerostin: Therapeutic Horizons Based Upon Its Actions
|
Costa, Aline G. |
|
2012 |
10 |
1 |
p. 64-72 |
artikel |
13 |
Secondary Fracture Prevention
|
Adler, Robert A. |
|
2012 |
10 |
1 |
p. 22-27 |
artikel |
14 |
Vitamin D in the New Millennium
|
Wimalawansa, Sunil J. |
|
2012 |
10 |
1 |
p. 4-15 |
artikel |